Addressing Comorbidities of Patients With Type 2 Diabetes: A Q&A With Philip Rabito, MD
Optimizing Outcomes From Pharmacologic Management of Type 2 Diabetes
Overcoming Challenges in Treatment of Patients With Type 2 Diabetes: A Q&A With Robert A. Gabbay, MD, PhD, FACP
Treatment Selection for Patients With Type 2 Diabetes: A Q&A With Om P. Ganda, MD
Managing Type 2 Diabetes and the Role of Sodium-Glucose Cotransporter 2 Inhibitors